In the adjacent non-tumor area, silencing Gal-1 downregulated ECM interaction and adhesion, immune regulation, signaling pathways related to platelet degranulation and Rho GTPase activate NADPH oxidase (Supplemental Fig. 2B). This evidence concerns the gene FMO5 and neoplasm.